IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q1 2022 Holdings

Filed 2022-05-16 | 6 holdings | $106.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Talaris Therapeutics IncCOM87410C104$28.9K2,932,60627.1%
Icosavax IncCOM45114M109$24.7K3,510,22823.2%
Jasper Therapeutics IncCOM471871103$20.8K5,852,98219.5%
Kezar Life Sciences IncCOM49372L100$13.8K828,71112.9%
Ventyx Biosciences Inc(VTYX)COM92332V107$12.4K910,30611.6%
Elevation Oncology IncCOM28623U101$6.0K2,370,1425.6%